Log In
Print
BCIQ
Print
Print this Print this
 

Stribild, elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (formerly Quad)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionFixed-dose combination tablet containing 150 mg cobicistat and 150 mg elvitegravir plus Truvada 200 mg emtricitabine/300 mg tenofovir
Molecular Target
Mechanism of ActionHIV integrase inhibitor; HIV reverse transcriptase inhibitor; Cytochrome P450 3A (CYP3A) inhibitor
Latest Stage of DevelopmentMarketed
IndicationHIV / AIDS
Partner

Japan Tobacco Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today